Cantor Fitzgerald Maintains Overweight on Elevance Health, Raises Price Target to $580
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has maintained an Overweight rating on Elevance Health (NYSE:ELV) and increased the price target from $547 to $580.

February 14, 2024 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald has maintained an Overweight rating on Elevance Health and raised the price target from $547 to $580.
The increase in price target by a reputable analyst firm like Cantor Fitzgerald typically signals a strong bullish sentiment on the stock, suggesting a positive outlook on Elevance Health's performance. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100